Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis

Neurochemical Research

Volumn 23, Issue 2, 1998, Pages 169-174

  Fujita, Kimikazu ^a   Kato, Toshiaki ^b   Yamauchi, Masamitsu ^a   Ando, Masato ^c   Honda, Masao ^d   Nagata, Yutaka ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c AICHI GAKUSEN UNIVERSITY   (Japan)

^d Yokohama City University   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); Glial fibrillary acidic protein (GFAP); Human spinal cord; Immunohistochemistry; Immunoreactivity; Motoneuron degeneration; Polyacrylamide gel electrophoresis (PAGE)

Indexed keywords

ANAZOLENE SODIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; POLYCLONAL ANTIBODY;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; SPINAL CORD; SPINAL CORD VENTRAL HORN;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; ROSANILINE DYES; SPINAL CORD;

EID: 0031934944     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022476724381     Document Type: Article

References (22)

1. Carascio, J. T., Mulvihill, M. M., Sterling, R., and Abrams, B. 1987. Amyotrophic lateral sclerosis; its natural history. Neurol. Clin. 5:1-8.
2. Nagata, Y., Okuya, M., Watanabe, R., and Honda, M. 1982. Regional distribution of cholinergic neurons in human spinal cord transection in the patients with and without motor neuron disease. Brain Res. 224:223-229.
3. Fujita, K., Ando, M., Yamauchi, M., Nagata, Y., and Honda, M. 1995. Alteration of transglutaminase activity in rat and human spinal cord after neuronal degeneration. Neurochem. Res. 20: 1195-1201.
4. Tezlaff, W., Graeber, M. B., Bisky, M. A., and Kreutzberg, G. W. 1988. Increased glial fibrillary acidic protein synthesis in astrocytes during retrograde reaction of the facial nucleus. Glia. 1: 90-95.
5. Fujita, K., Yamauchi, M., Shibayama, K., Ando, M., Honda, M., and Nagata, Y. 1996. Decreased cytochrome c oxidase activity but unchanged Superoxide dismutase and glutathione peroxidase activities in the spinal cord of patients with amyotrophic lateral sclerosis. J. Neurosci. Res. 45:276-281.
6. Stone, G. C., and Hammerschlag, R. 1981. Differential effects of cobalt on the initiation of rat axonal transport. Cell. Mol. Neurobiol. 1:3-17.
7. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electro-blotted onto polyvinyl difluoride membrane. J. Biol. Chem. 262:10035-10038.
8. 2-macroglobulin and von Wilbrand factor posses covalently linked ABORh blood group antigens in subjects with corresponding ABO phenotypes. Blood. 82:663-668.
9. Guedson, J.-L., Ternyck, T., and Avrameas, S. 1979. The use of avidin-biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem. 27:1131-1139.
10. Nakamura, Y., Takeda, M., Aimoto, S., Hojo, H., Takao, T., Shimonishi, Y., Horiguchi, S., and Nishimura, T. 1992. Assembly regulatory domain of glial fibrillary acidic protein; a single phosphorylation diminishes its assembly-accelerating property. J. Biol. Chem. 267:23269-23274.
11. Eng, L. F., and Rubinstein, L. J. 1978. Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J. Histochem. Cytochem. 26:513-522.
12. Fujita, K., Yamauchi, M., Matsui, T., Titani, K., Takahashi, H., Kato, T., Isomura, G., Ando, M., and Nagata, Y. 1997. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mouse. Brain Res. in press.
13. Bigbee, J. M., Bigner, D. D., Pegram, C., and Eng, L. F. 1983. Study of glial fibrillary acidic protein in human glioma in culture and as a solid tumor. J. Neurochem. 40:460-467.
14. DeArmond, S. J., Fajardo, M., Naughton, S. A., and Eng, L. F. 1983. Degradation of glial fibrillary acidic protein by a calcium dependent protease, an electroblot study. Brain Res. 262:275-282.
15. Murachi, T. 1989. Intracellular proteolytic system involving calpain and calpastatin. Biochem. Int. 18:263-294.
16. Benuck, M., Banny-Schwartz, M., DeGuzman, T., and Lajtha, A. 1996. Changes in brain protease activity in aging. J. Neurochem. 67:2019-2029.
17. Gomi, H., Yokoyama, T., Fujimoto, K., Ikeda, T., Katoh, A., Itoh, T., Itohara, S. 1995. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptable to scrapie prions. Neuron. 14:29-41.
18. Liedtke, W., Edelman, W., Bieri, P. L., Chiu, F. C., Cowan, N. J., Kuchelapati, R., and Raine, C. S. 1966. GFAP is necessary for the integrity of CNS white matter architecture and ion-term maintenance of myelination. Neuron. 17:607-615.
19. Delacourte, A. 1990. General and dramatic glial reaction in Alzheimer brain Neurology. 40:33-37.
20. Troost, D., Sillevis Smitt, P. A. E., Dejong, J. M. B. V., and Swaad, D. F. 1992. Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta. Neuropathol. 84:664-673.
21. Rosengren, L. E., Lycke, J., and Andersen, O. 1995. Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit. J. Neurol. Sci. 133:61-65.
22. Rasengren, L. E., Karlsson, J.-E., Karlsson, J.-O., Persson, L. I., and Wikkelsi, C. 1996. Patients with amyotrophic lateral sclerosis and other neuro-degenerative disease have increased levels of neurofilament protein in CSF. J. Neurochem. 67:2013-2018.